| Literature DB >> 23937693 |
Radmehr Shafiee1, Javad Javanbakht2, Nahid Atyabi2, Pegah Kheradmand3, Danial Kheradmand4, Alimohammad Bahrami5, Hasti Daraei6, Farshid Khadivar1.
Abstract
BACKGROUND: The human "Elston and Ellis grading method" was utilized in dogs with mammary tumor to examine its relation to prognosis in this species, based on a 2-year follow-up period. Although cytopathology is widely used for early diagnosis of human neoplasms, it is not commonly performed in veterinary medicine. Our objectives in this study were to identify cytopathology criteria of malignancy for canine mammary tumors and the frequency of different types of mammary lesions and their relationship with histologic grade was investigated. Another aim of this study was to differentiate the simple and adenocarcinoma tumors from the complex or mixed tumor described by Elston and Ellis grading method.Entities:
Keywords: Cytohistopathology; Dog; Grading of tumours; Mammary glands; Tumour
Year: 2013 PMID: 23937693 PMCID: PMC3765114 DOI: 10.1186/1475-2867-13-79
Source DB: PubMed Journal: Cancer Cell Int ISSN: 1475-2867 Impact factor: 5.722
Figure 1The relative risk of neoplasms of the mammary gland in female dogs in individual age and tumor size categories.
Cytological and histopathological analysis of pre-operative and sampled during surgery from the mammary neoplasms of the 15 females dogs together with signalment of bitches included in the this study
| 1 | Right cranio and caudo inguinal lobes / left caudo-inguinal lobe | carcinoma | Malignant | Complex carcinoma | Malignant |
| 2 | Left thoracic lobe | carcinoma | Malignant | Malignant mixed tumour | Malignant |
| 3 | Left cranio abdominal lobe | Benign secretory | Benign | Benign mixed tumour | Benign |
| 4 | Left cranio and caudo inguinal lobes | carcinoma | Malignant | Complex carcinoma | Malignant |
| 5 | Right cranio inguinal lobe | carcinoma | Malignant | Complex carcinoma | Malignant |
| 6 | Left caudo inguinal lobe | carcinoma | Malignant | Simple carcinoma | Malignant |
| 7 | Left cranio inguinal lobe | adenocarcinoma | Malignant | Malignant mixed tumour | Malignant |
| 8 | Left cranio and caudo inguinal lobe and right caudo-inguinal lobe | carcinoma | Malignant | Complex carcinoma | Malignant |
| 9 | Right caudo inguinal lobe | Benign secretory | Benign | Benign mixed tumour | Benign |
| 10 | Left cranio inguinal lobe | carcinoma | Malignant | Complex carcinoma | Malignant |
| 11 | Left cranio and caudo abdominal lobes | carcinoma | Malignant | Solid adenocarcinoma | Malignant |
| 12 | Right cranio inguinal lobe | hyperplasia | Benign | Cystic hyperplasia | Malignant |
| 13 | Left cranio inguinal lobe | carcinoma | Malignant | Malignant mixed tumour | Malignant |
| 14 | Right cranio-abdominal lobe | adenocarcinoma | Malignant | Papillary adenocarcinoma | Malignant |
| 15 | Left thoracic lobe | adenocarcinoma | Malignant | Solid adenocarcinoma | Malignant |
Figure 2Cytological analysis of pre-operative fine needle aspirates and histopathological analysis of mammary tumour masses sampled during surgery in the 15 females dogs.
Figure 3Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours. A: Fine-needle aspirate from a mammary carcinoma in adog. Variation in cell (anisocytosis) and nuclear. (anisokaryosis) size are present, May-Grunwald-Giemsa staining method, 1000X. B: Adenocarcinoma: Malignant mammary epithelial cells: Fine needle aspirate with hypercellular pleomorphic, large hyperchromatic naked cells with coarse and abundant chromatin granules and vacuolar changes, May-Grunwald-Giemsa staining method, 1000X. C: Malignant multinucleated mammary epithelial cell; nuclei exhibit nuclear criteria of malignancy; nuclei superimposed and in different focal planes. May-Grunwald-Giemsa staining method, 1000X. D: Cytological appearance of spindle shape cells, May-Grunwald-Giemsa staining method, 400X. E: Myoepithelial cells (spindle shape) with abundant chromatin granules (red arrows) in adenocarcinoma, May-Grunwald-Giemsa staining method, 1000X. F and G: This cluster of cells shows multinucleated cells containing several irregularly sized nucleiare found in some cases, May-Grunwald-Giemsa staining method, 1000X. H: Fine-needle aspiration biopsy. Benign mammary tumor epithelial cell cluster. Cytological appearance of uniform epithelial cells, May-Grunwald-Giemsa staining method, 400X.
Figure 4Histopathological evaluation of mammary gland tumours in dogs. A: Solid adenocarcinoma; The presence of neoplastic, mitotic and inflammatory cells (H&E, X 200.), B: Cartilage tissue cells due to metaplasia in malignant mixed tumour H&E, X 400. C: Myoepithelial reaction included with spindle shape cells in carcinoma, H&E, X 400. D and E: A cystic tumour of adenocarcinoma showing local invasion of interlobular connective tissue and note the high mitotic index and also different mitotic figures (H&E, (H&E, × 400 and 200). F: Papillary adenocarcinoma proliferating neoplastic epithelial cells in the form of papillary projections and presence of mitotic figures. H&E, 200×, G and H: Beinign mixed mammay tumour. Tumour tissue showing epithelial and myoepithelial components, 400×, I: The presence of neoplastics emboli within the dermal lympathic vessels, which was occasionally observed with some of the most aggressive adenocarcinoma, leads to blockage of the superficial dermal lymphatic drainage (H&E, X 200), J: Cholesterol cleft in malignant mixed tumour, (H&E, X 400). K: Cells exhibit variable numbers of mitoses are found; or, the second population of cells may have oval to fusiform vesicular nuclei with an extensive amount of eosinophilic cytoplasm and distinct cells margins (H&E, X 400) L: Haemorrhage foci and the central necrotic areas are interpreted as an indication that the neoplastic cells are growing faster and that there is therefore a higher risk of progression to invasive carcinoma (H&E, X 400).
Relationship between histological grading and tumour type together with number and percentage of cases in 15 dogs with mammary tumour
| Cystic hyperplasia | 1(6.7%) | _ | _ | 1(6.7%) |
| Solid adenocarcinoma | _ | _ | 1(6.7%) | 1(6.7%) |
| Papillary adenocarcinoma | _ | 1(6.7%) | 1(6.7%) | 2(13.3%) |
| Simple carcinoma | _ | _ | 1(6.7%) | 1(6.7%) |
| Complex carcinoma | _ | 3(20%) | 2(13.3%) | 5(33.3%) |
| Benign mixed tumour | 1(6.7%) | 1(6.7%) | _ | 2(13.3%) |
| Malignant mixed tumor | _ | 1(6.7%) | 2(13.3%) | 3(20%) |
| Total | 2(13.3%) | 6(40%) | 7(46.7%) | 15(100%) |